/PRNewswire/ -- Emulait, a pioneering force in the baby care industry, proudly announces a strategic partnership with Jet-Set-Go, a premier name in North...
On its website, the company describes its mission as "[closing] the gap between breast and bottle" in an effort to make breastfeeding accessible to every woman.
Baby product innovations are often slow. Baby monitors are smarter, strollers are safer, but baby bottles really haven’t changed a whole lot since we were all toddlers.
Alpha Healthcare Acquisition Corp. III (NASDAQ:ALPA – Get Rating) and DarioHealth (NASDAQ:DRIO – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, valuation, profitability, risk, analyst recommendations and institutional ownership. Valuation & Earnings This table compares Alpha […]
DarioHealth (NASDAQ:DRIO – Get Rating) had its price target lowered by Alliance Global Partners from $7.50 to $6.00 in a report published on Friday, The Fly reports. Separately, Craig Hallum dropped their price target on shares of DarioHealth from $14.00 to $8.00 in a research report on Friday. DarioHealth Price Performance Shares of NASDAQ DRIO […]
DarioHealth (NASDAQ:DRIO – Get Rating) had its target price reduced by Craig Hallum from $14.00 to $8.00 in a report released on Friday, The Fly reports. DarioHealth Stock Performance DarioHealth stock opened at $3.79 on Friday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 2.98 and a current ratio of 3.39. […]
DarioHealth (NASDAQ:DRIO – Get Rating) had its target price lowered by Alliance Global Partners from $7.50 to $6.00 in a research note published on Friday, The Fly reports. Separately, Craig Hallum cut their price target on shares of DarioHealth from $14.00 to $8.00 in a report on Friday. DarioHealth Stock Performance Shares of DarioHealth stock […]
Las Vegas-based startup Emulait launched its customized baby bottles in March and has a waitlist of 50,000 customers, according to founder and CEO Shilo Ben Zeev.
DarioHealth (NASDAQ:DRIO – Get Rating) and Pulmonx (NASDAQ:LUNG – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, risk, valuation, dividends and profitability. Insider and Institutional Ownership 35.8% of DarioHealth shares are held by […]